Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0001562180-24-006013

Chief Scientific Officer acquired 60,230 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Danos Olivier · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-28 Grant or award : show line 1 in the form +1,363 $9.95 $13,555 126,216 D
2024-08-01 Grant or award : show line 2 in the form +58,867 185,083 D
Loading xslF345X05/primarydocument.xml…